Clinical Trials Directory

Trials / Unknown

UnknownNCT03987945

Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai

Prognostic Implications of Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation at Shanghai Tenth People's Hospital

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The prognostic implication of left atrial appendage occlusion (LAAO) procedure in non-valvular atrial fibrillation (NVAF) patients from China is still unclear. We aim to investigate the impact of LAAO procedure on subsequent clinical outcomes in patients from China.

Detailed description

Although the left atrial appendage occlusion (LAAO) procedure has increasingly been performed to prevent the occurrence of ischemic stroke events among patients with non-valvular atrial fibrillation (NVAF), the clinical benefits and prognostic implications of which have not been well characterized in patients from China. As a result, we aim to conduct an observational study to explore the prognostic impact of LAAO in patient with NVAF who are hospitalized in Shanghai Tenth People's Hospital.

Conditions

Interventions

TypeNameDescription
DEVICEleft atrial appendage occlusion devicesAll NVAF patients who are admitted for receiving left atrial appendage occlusion procedure, including Watchman, LAmbre, Lefort, and Leftear deveices.

Timeline

Start date
2019-05-01
Primary completion
2019-12-31
Completion
2020-06-30
First posted
2019-06-17
Last updated
2019-06-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03987945. Inclusion in this directory is not an endorsement.